Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The mRNA-LNP vaccines – the good, the bad and the ugly?
Botond Z. Igyártó, Zhen Qin
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 14

Showing 14 citing articles:

Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy
Saber İmani, Xiaoyan Li, Keyi Chen, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access | Times Cited: 4
Cerebromicrovascular mechanisms contributing to long COVID: implications for neurocognitive health
Mónika Fekete, Andrea Ceglédi, Ágnes Szappanos, et al.
GeroScience (2025)
Open Access | Times Cited: 2
Codon-optimization in gene therapy: promises, prospects and challenges
Anastasiia Iu. Paremskaia, Anna A. Kogan, А. А. Мурашкина, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 13
Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery
Jialiang Wang, Yaopeng Ding, K. Chul Chong, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1148-1148
Open Access | Times Cited: 13
A SARS-CoV-2 mucosal nanovaccine based on assembly of maltodextrin, STING agonist and polyethyleneimine
Yu Tian, Liang Hu, Qingrui Huang, et al.
International Journal of Biological Macromolecules (2025), pp. 139395-139395
Closed Access
Model‐Informed Drug Development Applications and Opportunities in mRNA‐LNP Therapeutics
Jiawei Zhou, Rohit Rao, Mark Shapiro, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access
Spike protein-related proteinopathies: a focus on the neurological side of spikeopathies
Andreas Posa
Annals of Anatomy - Anatomischer Anzeiger (2025), pp. 152662-152662
Open Access
The therapeutic effect of mRNA vaccines in glioma: a comprehensive review
Fatemeh Afrashteh, Simin Seyedpour, Nima Rezaei
Expert Review of Clinical Immunology (2025)
Closed Access
mRNA vaccines for prostate cancer: A novel promising immunotherapy
Yaxiong Tang, Xianyanling Yi, Jianzhong Ai
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189333-189333
Closed Access
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
Reports of Batch-Dependent Suspected Adverse Events of the BNT162b2 mRNA COVID-19 Vaccine: Comparison of Results from Denmark and Sweden
Vibeke Manniche, Max Schmeling, Jonathan D. Gilthorpe, et al.
Medicina (2024) Vol. 60, Iss. 8, pp. 1343-1343
Open Access | Times Cited: 2
Pharmaceutical product recall and educated hesitancy towards new drugs and novel vaccines
Peter Rhodes, Peter Parry
International Journal of Risk & Safety in Medicine (2024) Vol. 35, Iss. 4, pp. 317-333
Closed Access | Times Cited: 2
Transplacental transmission of mRNA injections confirmed: does this evidence by Hanna and colleagues support their proposition as a promising prenatal gene therapy?
Siguna Mueller
(2024)
Open Access
mRNA Technologies Danger
M. V. Supotnitskiy
Journal of NBC Protection Corps (2024) Vol. 8, Iss. 3, pp. 205-231
Open Access
Antigen Delivery Platforms for Next-Generation Coronavirus Vaccines
Aziz Alami Chentoufi, Jeffrey B. Ulmer, Lbachir BenMohamed
Vaccines (2024) Vol. 13, Iss. 1, pp. 30-30
Open Access
Page 1

Scroll to top